Geneva Biotech is a privately held biotechnology company, based in Geneva, Switzerland. Founded in 2012

Geneva Biotech SynBac™

Intelligent DNA delivery systems

Welcome Guest \\ Login


Technology Description

Traditional process scale up using baculovirus is notoriously problematic, with yields dropping progressively during scale up. SynBac™ are minimized baculoviral genomes created using modern synthetic biology techniques. The SynBac project aims to transform fermenter-scale baculoviral production of drug targets, and manufacturing scale production of biopharmaceuticals by creating minimal baculoviral genomes displaying exceptional DNA stability. In addition to improved DNA stability, our minimized genomes form the starting point for applicaions that require large DNA cargo delivery to mammalian cells, primary cells, or organs.


EMBL and IStLS carried out a comparative genome analysis and intense data mining to identify regions of the baculovirus genome that are potentially harmful for DNA stability, or are otherwise non-essential and require re engineering (see Figure 1 below). Large sections of the AcMNPV genome are being rewired and tested for critical parameters such as expression yield and DNA stability. In an iterative process, improved genomes are being used as templates for further rounds of genome minimization and optimization.

References and Downloads

Use MultiBac™ protocols (click here) to assemble SynBac™ Viruses

Click here to download SynBac reference 1

Click here to download baculovirus DNA instability reference 1

Click here to download baculovirus DNA instability reference 2

Click here to download baculovirus DNA instability reference 3

Below is a schematic representation of the AcMNPV genome (circle map), with the rewiring target of the SynBac1.0 genome indicated by the shaded triangle.



SynBac™ Kit + Competent Cells 1490.00€ ENQUIRY

Competent Cells

DH10SynBac (12 x 100µl) 960.00€ ENQUIRY
PirHC (12 x 100µl) 960.00€ ENQUIRY


pACEBac1 (5µg) 279.00€ ENQUIRY
pACEBac2 (5µg) 279.00€ ENQUIRY
pIDK (5µg) 279.00€ ENQUIRY
pIDC (5µg) 279.00€ ENQUIRY
pIDS (5µg) 279.00€ ENQUIRY

Dual Plasmids

pFL (5µg) 319.00€ ENQUIRY
pKL (5µg) 319.00€ ENQUIRY
pSPL (5µg) 319.00€ ENQUIRY
pUCDM (5µg) 319.00€ ENQUIRY

Dual Mammalian Insect Cell Plasmids

pFL-IM (5µg) 419.00€ ENQUIRY
pKL-IM (5µg) 419.00€ ENQUIRY
pSPL-IM (5µg) 419.00€ ENQUIRY
pUCDM-IM (5µg) 419.00€ ENQUIRY


E.coli cell expression

Research Highlights

our r&d View all

Latest News

T-CELL AND B-CELL TRANSDUCTION TECHNOLOGIES Geneva Biotech releases the first efficient non-lentiviral transduction system for immortal T-cells and B-cells. Please ...

View all

Contact Us